From one colonic carcinoma chemically induced in the rat, 2 sublines of tumor cells have been cloned, one (PROb) inducing progressive tumors, the other (REGb) generating tumors that regress a few weeks after S.C. injection into syngeneic hosts. Our study was aimed at comparing cellular immunity betw
Identification and characterization of a rat protein (P 105) auto-antigenic in rats bearing a progressive syngeneic colon carcinoma
✍ Scribed by Hervé M. Blottière; Antoine Menoret; Cédric Burg; Jean Yves Douillard; Jacques Le Pendu
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- French
- Weight
- 973 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Sera from BDIX rats inoculated with 2 tumor clones derived from a single syngeneic colon carcinoma were assayed by Western blotting for the presence of antibodies against the grafted tumor. The PROb clone is progressive and produces metastases. We observed that rats bearing this tumor developed antibodies against an unglycosylated water-soluble protein of 105 kDa. The magnitude of this humoral response, as assessed by the intensity of the signal on immunoblots, was inversely correlated with survival of the rats. Furthermore, rats inoculated with the REGb clone, which is immunologically rejected, never developed detectable antibodies against the tumor. Antisera from rats injected with PROb tumor detected p105 antigen in cellular extracts from the REGb clone and from a series of rat and human cell lines. This protein was also detected in variable amounts in some normal adult and fetal tissues. Treatment of PROb or REGb cells by either interferon-y or heat shock did not significantly alter the expression of the p I05 auto-antigen.
📜 SIMILAR VOLUMES